Beyond platelet-mediated actions, the hypothesized mechanisms for NA-NSAIDs in this study included anti-inflammatory effects via COX-1 and − 2 inhibition, and subsequent inhibition of prostaglandin generation from arachidonic acid, as well as COX-independent pathways associated cancer progression [19]. This evidence concerns the gene PTGS1 and cancer.